bioRxiv preprint doi: https://doi.org/10.1101/2020.05.22.110080; this version posted May 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. A clinically validated human capillary blood transcriptome test for global systems biology studies Ryan Toma1, Ben Pelle2, Nathan Duval1, Matthew M Parks1, Vishakh Gopu1, Hal Tily1, Andrew Hatch1, Ally Perlina1, Guruduth Banavar1, and Momchilo Vuyisich1* 1 Viome, Inc., Bellevue, WA, USA, viome.com, 2 The University of Washington, Seattle, USA *Corresponding author: Momchilo Vuyisich,
[email protected] Abstract should be integrated into longitudinal, population- scale, systems biology studies. Chronic diseases are the leading cause of morbidity and mortality globally. Yet, the majority of Introduction them have unknown etiologies, and genetic Quantitative gene expression analysis contribution is weak. In addition, many of the chronic provides a global snapshot of tissue function. The diseases go through the cycles of relapse and human transcriptome varies with tissue type, remission, during which the genomic DNA does not developmental stage, environmental stimuli, and change. This strongly suggests that human gene health/disease state (Frith et al., 2005; Lin et al., 2019; expression is the main driver of chronic disease onset Marioni et al., 2008; Mortazavi et al., 2008; Velculescu and relapses. To identify the etiology of chronic et al., 1999). Changes in the expression patterns can diseases and develop more effective preventative provide insights into the molecular mechanisms of measures, a comprehensive gene expression analysis disease onset and progression. In the era of precision of the human body is needed.